Kim Byung Joo, Lim Hyun-Ho, Yang Dong Ki, Jun Jae Yeoul, Chang In Youb, Park Chul-Seung, So Insuk, Stanfield Peter R, Kim Ki Whan
Department of Physiology and Biophysics, Seoul National University College of Medicine, Seoul, Korea.
Gastroenterology. 2005 Nov;129(5):1504-17. doi: 10.1053/j.gastro.2005.08.016.
BACKGROUND & AIMS: Interstitial cells of Cajal are pacemakers in the gastrointestinal tract, regulating rhythmicity by activating nonselective cation channels. In Caenorhabditis elegans, the melastatin-type transient receptor potential (TRPM) channel, especially TRPM7, was suggested as being involved in defecation rhythm. The aim here was to show that the nonselective cation channel in interstitial cells of Cajal in mouse small intestine has properties essentially identical to those of murine TRPM7, heterologously expressed in human embryonic kidney cells.
The patch-clamp technique for whole-cell recording was used in cultured or single interstitial cells of Cajal. TRPM7-specific small interfering RNAs were used for specific inhibition of TRPM7.
Electrophysiological and pharmacological properties of the nonselective cation channel in interstitial cells of Cajal were the same as those of TRPM7. Reverse-transcription polymerase chain reaction, Western blotting, and immunohistochemistry all showed abundant and localized expression of TRPM7 messenger RNA and protein in mouse small intestine. Treatment of primary cultured interstitial cells of Cajal with TRPM7-specific small interfering RNA resulted in inhibition of pacemaking activity.
TRPM7 is required for intestinal pacemaking. The protein is a likely potential target for pharmacological treatment of motor disorders of the gut.
Cajal间质细胞是胃肠道的起搏细胞,通过激活非选择性阳离子通道来调节节律性。在秀丽隐杆线虫中,褪黑素型瞬时受体电位(TRPM)通道,尤其是TRPM7,被认为参与排便节律。本研究旨在表明,小鼠小肠Cajal间质细胞中的非选择性阳离子通道的特性与在人胚肾细胞中异源表达的小鼠TRPM7基本相同。
采用膜片钳全细胞记录技术对培养的或单个的Cajal间质细胞进行研究。使用TRPM7特异性小干扰RNA对TRPM7进行特异性抑制。
Cajal间质细胞中非选择性阳离子通道的电生理和药理学特性与TRPM7相同。逆转录聚合酶链反应、蛋白质印迹法和免疫组织化学均显示TRPM7信使核糖核酸和蛋白质在小鼠小肠中大量且定位表达。用TRPM7特异性小干扰RNA处理原代培养的Cajal间质细胞可导致起搏活性受到抑制。
TRPM7是肠道起搏所必需的。该蛋白可能是肠道运动障碍药物治疗的潜在靶点。